期刊文献+

变异链球菌葡糖基转移酶植物表达质粒p2355-gtfB的构建

Construction of plant expression plasmid p2355-gtfB containing glucosyltransferase B of Streptococcus mutans
下载PDF
导出
摘要 目的构建含变异链球菌葡糖基转移酶多个免疫显性抗原表位的植物表达质粒p2355-gtfB,为其转化植物研究奠定物质基础,为可食防龋疫苗研究提供条件。方法以真核表达质粒pcDNA3-gtfB为模板,通过聚合酶链反应(polymerase chain reaction,PCR)扩增含编码变异链球菌葡糖基转移酶抗原表位的目的基因gtfB。将回收纯化的PCR产物经T-A克隆技术克隆于中间载体pMD18-T,双酶切鉴定插入方向后,将目的基因从中间载体释放,再克隆至高效的植物表达载体p2355,用电转化法转化根癌农杆菌EHA105,对重组质粒阳性克隆株进行筛选与鉴定。结果通过对重组质粒T-gtfB进行酶切图谱分析,获得2.9 kb和3.7 kb的2个片断,将重组质粒p2355-gtfB进行酶切、PCR及测序分析,显示p2355-gtfB中插入基因长度为3 675 bp,基因序列与双脱氧链终止法的测定结果相同,证明植物表达质粒p2355-gtfB构建成功,开放阅读框架正确。结论本研究成功构建了含变异链球菌多个葡糖基转移酶免疫显性抗原表位编码基因的植物表达质粒p2355-gtfB,为可食性防龋疫苗的研究奠定了基础。 Objective To construct plant plasmid p2355gtfB which contains multiple catalytic sites and antigen epitopes of glucosyltransferase of Streptococcus mtttans Methods Plasmid peDNA3gtfB was used as template to obtain the gtfB by PCR amplification. Then gtfB was inserted into intermediate vector pMDI8T, subcloned from the recombi nant plasmid TgtfB to plant expression vector p2355, then p2355gtfB was transformed into Agrobacterium tumefaeiens EHA105 by electroporation. Results Genetic segments 2.9 kb and 3.7 kb were obtained through restriction enzyme mapping analysis and DNA sequencing, and inserted gene 3 675 bp was shown in the construction recombinant plasmid p2355gtfB through series analysis and detection. Conclusion The recombinant plasmid was constructed successfully. This research provided basis for further study on plants vaccine against dental caries.
出处 《广东牙病防治》 2012年第9期473-478,共6页 Journal of Dental Prevention and Treatment
基金 国家自然科学基金资助项目(30160086) 教育部高等学校特色专业建设项目(教高函[2007]31号) 贵州省高等学校示范性专业建设项目(黔教高发[2008]184号) 贵州省高层次人才科研条件特助经费项目(TZJF-2011年-30号)
关键词 防龋疫苗 变异链球菌 葡糖转移酶类 质粒 龋齿/预防与控制 链球菌 变异 葡糖转移酶类 质粒 Anti-earies vaccine Streptococcus mutans Glueosyltransferase PlasmidsDental caries/prevention and eontrol Streptococcu.~ muttms Glucosyhranst^rases Plasmids
  • 相关文献

参考文献17

  • 1Nakano Y J, Kuramitsu HK. Mechanism of Streptococcus mutans glu- cosvltransirases hybrid-enzyme analysis. J Bacteriol, 1992, 174 (17) :5639-5646.
  • 2Chia JS, Lin RH, Lin SW, et al. Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a sub- sequence peptide. Inict hnnnm, 1993,61 ( 11 ) :4689-4695.
  • 3Smith DJ, Taubman MA, King WF, el a]. Immunological character- istics of a synthetic peptide associated with a catalytic domain of mu- tans streptococcal glucosyhransferase. Infect lmmun, 1994,62 (12) : 5470-5476.
  • 4Ahmad P, Ashraf M, Younis M, et al. Role of transgenic plants in agriculture and biopharming. Biotechnol Adv, 2012,30 ( 3 ) : 524- 540.
  • 5Pelosi A, Shepherd R, Walmsley AM. Delivery of plant-made vac- cines and therapeutics. Biotechnol Aclv, 2012,30 ( 2 ) :440-448.
  • 6Shiroza T, Ueda S, Kuramitsu HK. Sequence analysis of the gtfB gene from Streptococcus mutans. Bacteriol, 1987, 169 (9) : 4263- 4270.
  • 7S.m JH, Yang XC, Xu QA, et al. Novel Epitopic Region of Glu- cosyhransferase B from Streptococcus mutans. Clin Vaccine Immu- nol, 2011,18(9) :1552-1561.
  • 8Guo JH, Jia R, Fan MW, et al. Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans. J Dent Res, 2004,83 ( 3 ) :266-270.
  • 9杨锦波,刘天佳,周学东.变形链球菌葡糖基转移酶真核表达质粒pcDNA3-gtfB的构建[J].华西口腔医学杂志,2001,19(4):249-252. 被引量:10
  • 10杨德琴,刘天佳,曹福娴,杨锦波,刘建国.变形链球菌表面蛋白和葡糖基转移酶基因疫苗免疫防龋实验研究:唾液和血清抗体水平测定[J].华西口腔医学杂志,2003,21(5):396-399. 被引量:5

二级参考文献22

  • 1[1]Loesche WJ, Rowan J, Straffon LH, et al. Association of Streptococcus mutans with human dental decay. Infect Immun, 1975,11(6):1252-1260
  • 2[2]Oho T, Shimazake Y, Mitoma M. Bovine milk antibodies against cell surface protein antigen PAc-glucosyltransferase fusion protein suppress cell adhesion and alter glucan synthesis of Streptococcus mutans. J Nutr, 1999,129(10):1836-1841
  • 3[8]Kawabata S, Terao Y, Fujiwara T, et al. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Infect Immun, 1999, 7(11): 5863-5868
  • 4[9]Saito M, Otake S, Ohmura M, et al. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant. J Infect Dis, 2001 ,183(5):823-826
  • 5[10]Deck RR, Dewilt CM, Donnelley JJ, et al. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.Vaccine, 1997,15(1):71-78
  • 6[11]Etrl HC, Xiang Z. Novel vaccine approaches. J Immunol, 1996, 156(10):3579-3582
  • 7[12]Taubman MA, Holmberg CJ, Smith DJ, et al. Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries. Infect Immun, 2001, 69(7):4210-4216
  • 8[13]Hajishengallis G, Michalek SM. Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol, 1999,14 (1):1-20
  • 9Chia J S,Infect Immun,1993年,61卷,11期,4689页
  • 10Hajishengallis G,Koga T and Russell MW.Affinity and specificity of the interactions between S.mutans antigen Ⅰ/Ⅱ and salivary components[].Journal of Dental Research.1994

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部